Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
40 studies found for:    celgene abi-007 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;   Rhabdomyosarcoma;   Ewing's Sarcoma;   Ewing's Tumor;   Sarcoma, Ewing's;   Sarcomas, Epitheliod;   Sarcoma, Soft Tissue;   Sarcoma, Spindle Cell;   Melanoma;   Malignant Melanoma;   Clinical Oncology;   Oncology, Medical;   Pediatrics, Osteosarcoma;   Osteogenic Sarcoma;   Osteosarcoma Tumor;   Sarcoma, Osteogenic;   Tumors;   Cancer;   Neoplasia;   Neoplasm;   Histiocytoma;   Fibrosarcoma;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
2 Recruiting Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Condition: Squamous Cell Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Abraxane (Induction);   Drug: Carboplatin (Induction);   Drug: Abraxane (Maintenance);   Other: Best Supportive Care (Maintenance)
3 Recruiting Treatment of Pancreatic Cancer With Abraxane
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Abraxane;   Drug: Gemcitabine
4 Recruiting Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Pancreatic Neoplasms
Interventions: Drug: nab-Paclitaxel;   Drug: Nivolumab;   Drug: Gemcitabine;   Drug: Carboplatin
5 Recruiting Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer
Condition: Metastatic Pancreas Adenocarcinoma
Interventions: Drug: 5FU;   Drug: nab-paclitaxel;   Drug: bevacizumab;   Drug: calcium leucovorin;   Drug: oxaliplatin
6 Recruiting A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention:
7 Recruiting ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: ACY-241
8 Recruiting Single Arm on the Tolerability of Weekly Nab-paclitaxel
Condition: Non Small Cell Lung Cancer (NSCLC)
Intervention: Drug: Nab-Paclitaxel
9 Recruiting Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
Conditions: Urothelial Carcinoma;   Bladder Cancer;   Transitional Cell Carcinoma
Interventions: Drug: nab-paclitaxel;   Drug: Gemcitabine
10 Recruiting Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Condition: Gastroesophageal Cancer
Interventions: Drug: nab-paclitaxel;   Biological: ramucirumab
11 Recruiting Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
Condition: Biliary Tract Cancer
Interventions: Drug: Abraxane (Nab-Paclitaxel);   Drug: Cisplatin;   Drug: Gemcitabine;   Behavioral: Phone Calls
12 Recruiting Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Palbociclib;   Drug: Nab-Paclitaxel
13 Recruiting Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC
Condition: STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Interventions: Drug: NAB-PACLITAXEL;   Drug: PACLITAXEL
14 Recruiting Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Lung Cancer
Condition: Small Cell Lung Cancer (SCLC)
Interventions: Drug: Nab-paclitaxel;   Drug: Gemcitabine
15 Recruiting NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma
Condition: Cancer of Stomach
Interventions: Drug: nab-paclitaxel;   Drug: FOLFOX
16 Recruiting Combining Abraxane With Capecitabine and Radiation Therapy for Consolidation of Treatment Following Induction Chemotherapy for Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Abraxane;   Drug: Capecitabine;   Radiation: Radiation Therapy;   Behavioral: Questionnaires
17 Recruiting A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
Condition: Carcinoma, Non-small-Cell Lung
Interventions: Drug: Necitumumab;   Drug: Nab-Paclitaxel;   Drug: Carboplatin
18 Recruiting Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
Condition: Unresectable Pancreatic Carcinoma
Interventions: Drug: Tocilizumab;   Drug: Gemcitabine;   Drug: nab-Paclitaxel
19 Recruiting A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer
Condition: Unresectable Biliary Tract Cancer
Intervention: Drug: nab-paclitaxel in combination with gemcitabine + cisplatin
20 Recruiting Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Nab-Paclitaxel;   Drug: Carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.